Your browser doesn't support javascript.
loading
Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer.
Blum, Joanne L; Laird, A Douglas; Litton, Jennifer K; Rugo, Hope S; Ettl, Johannes; Hurvitz, Sara A; Martin, Miguel; Roché, Henri H; Lee, Kyung-Hun; Goodwin, Annabel; Chen, Ying; Lanzalone, Silvana; Chelliserry, Jijumon; Czibere, Akos; Hopkins, Julia F; Albacker, Lee A; Mina, Lida A.
Afiliação
  • Blum JL; Baylor Charles A. Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, Texas.
  • Laird AD; Pfizer Inc., La Jolla, California.
  • Litton JK; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rugo HS; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
  • Ettl J; Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
  • Hurvitz SA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain.
  • Roché HH; Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse, France.
  • Lee KH; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Goodwin A; Concord Repatriation General Hospital, Sydney, Australia.
  • Chen Y; Pfizer Inc., La Jolla, California.
  • Lanzalone S; Pfizer Inc., Milan, Italy.
  • Chelliserry J; Pfizer Inc., La Jolla, California.
  • Czibere A; Pfizer Inc., Cambridge, Massachusetts.
  • Hopkins JF; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Albacker LA; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Mina LA; Banner MD Anderson Cancer Center at Banner Gateway Medical Center, Gilbert, Arizona.
Clin Cancer Res ; 28(7): 1383-1390, 2022 04 01.
Article em En | MEDLINE | ID: mdl-35091441

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2022 Tipo de documento: Article